Immunogenicity of Intramuscular and Intradermal IPV

NCT04063150 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

958

Enrollment

FED

Sponsor class

Stopped COVID-19 pandemic

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: fIPV (0.1 mL) ID
BIOLOGICAL: fIPV (0.1mL) IM
BIOLOGICAL: fIPV (0.2mL) IM
BIOLOGICAL: IPV

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]